• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Did Defense Momentum and Vision 2027 Targets Just Shift Ducommun's (DCO) Investment Narrative?

    Simply Wall St·04/03/2026 15:19:03
    Listen to the news
    • In recent days, Ducommun has reported that strong defense demand, especially in missile programs, is helping counter ongoing commercial aviation weakness tied to Boeing’s inventory destocking.
    • The company’s Vision 2027 plan, aiming for US$950–US$1.00 billion in revenue and 18% margins with help from acquisitions, highlights how management is leaning on deal-making alongside organic initiatives to reshape the business mix and financial profile.
    • We’ll now examine how Ducommun’s defense-driven momentum and Vision 2027 targets may influence the company’s longer-term investment narrative.

    AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

    Ducommun Investment Narrative Recap

    To own Ducommun, you have to believe that its defense exposure, especially missiles, can offset choppy commercial aerospace demand while management works toward the Vision 2027 revenue and margin goals. The recent share pullback tied to geopolitical tensions looks more like broader risk-off trading than a fundamental change to Ducommun’s key near term catalyst, which remains execution on defense programs versus the biggest current risk around customer and program concentration.

    The Vision 2027 plan, targeting US$950–US$1,000 million in revenue and 18% margins with help from acquisitions, is the announcement that ties most directly into today’s debate. It frames how Ducommun might use its balance sheet and credit facilities to add scale and mix shift, even as investors weigh the benefits of defense-driven growth against the risk that U.S. defense budget or platform priorities could move away from Ducommun’s core missile and radar programs.

    Yet against this defense momentum, investors still need to watch how exposed Ducommun is if U.S. program priorities shift...

    Read the full narrative on Ducommun (it's free!)

    Ducommun's narrative projects $1.0 billion revenue and $90.8 million earnings by 2029. This requires 7.5% yearly revenue growth and a $124.7 million earnings increase from -$33.9 million today.

    Uncover how Ducommun's forecasts yield a $143.60 fair value, a 13% upside to its current price.

    Exploring Other Perspectives

    DCO 1-Year Stock Price Chart
    DCO 1-Year Stock Price Chart

    Two fair value estimates from the Simply Wall St Community span roughly US$143.60 to US$199.28, highlighting how far apart individual views can be. When you set those against Ducommun’s growing dependence on defense programs, it underlines why many market participants are weighing both upside from defense demand and the concentration risk before forming a view on the company’s longer term performance.

    Explore 2 other fair value estimates on Ducommun - why the stock might be worth just $143.60!

    Reach Your Own Conclusion

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    No Opportunity In Ducommun?

    Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.